Scientists looking for evidence of the gut's involvement in cognitive and mood problems related to chemotherapy treatment are testing their theories with the help of an unsavory rodent habit: eating feces.
Oct 23, 2019
0
10
A gel that can be injected into the abdominal cavity to deliver very local chemotherapy for weeks, could be a better alternative to the chemo abdominal rinses that are common today. Professor Patricia Dankers of Eindhoven ...
May 1, 2019
0
1
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...
Dec 6, 2018
0
2070
Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to ...
Jun 3, 2018
0
6
For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much ...
Apr 16, 2018
0
1007
The memory and thinking problems experienced by cancer survivors, known as "chemo brain" or "chemo fog," are not just the result of chemotherapy treatment, they may start as tumors form and develop, suggests a Baycrest-led ...
Nov 21, 2017
0
6
(HealthDay)—"Chemo brain"—the mental fog common after breast cancer treatment—can persist for six months, new research shows.
Jan 11, 2017
0
3
During and after chemotherapy, many cancer patients describe feeling a mental fog, a condition that has been dubbed "chemo brain." Why this happens is unclear, but researchers have found a new clue to understanding this syndrome. ...
May 25, 2016
0
22
Hair loss is one of the most despised side effects of chemotherapy, and now breast cancer patients are getting a new way to save their locks.
Dec 8, 2015
0
22
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease—good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.
Sep 28, 2015
0
326
